Susanna Naggie receives Oswald Avery Award for Early Achievement

Monday, October 8, 2018
Susanna Naggie, MD, MHS

The Infectious Diseases Society of America (IDSA) has presented its 2018 Oswald Avery Award for Early Achievement to the DCRI’s Susanna Naggie, MD, MHS, for her novel research on the treatment of patients co-infected with HIV and hepatitis C virus (HCV).

The award, which will be formally presented at ID Week 2018 in San Francisco, recognizes members or fellows of IDSA age 45 or younger who have demonstrated outstanding achievements in an area of infectious diseases.

“I was very surprised because I had no idea I’d been nominated,” Naggie said. “When I learned that two of my colleagues from outside of Duke nominated me, it meant a lot to know they found my work meaningful. As investigators we hope that our work is impactful and ultimately translates to improved health of our patients.”

Naggie’s research focuses on the mechanisms of accelerated liver fibrogenesis in HIV/HCV-infected patients. Her work has helped define the role of pharmacogenomics and mechanistic studies of HCV treatment response in these patients, including studies of single-nucleotide polymorphisms in HCV therapy and associated liver disease.

Read complete article on the DCRI Blog